MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20247135

June 27, 2024

国药准字H20213198

Drug Information

利伐沙班片

片剂

2.5mg

化学药品

June 27, 2024

Company Information

Applicant Company

吉林省梅河口市梧桐路1888号,吉林省梅河口市湘江路66号(一照多址)

Manufacturing Company

吉林省梅河口市梧桐路2588号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath